Sign In
NewsRadar

Oxford Nanopore Technologies

Oxford Nanopore Technologies is developing a technology platform for the electronic label-free analysis of single molecules.

The company’s platform technology uses real-time electronic measurement of current through small holes (nanopores) to identify molecules of interest as they interact with the nanopore.


• Show past press releases
• Edit this company

Contact Information
Address:
 
 

Phone:
Fax:
Web:
Contact:
 
 
Edmund Cartwright House, 4 Robert Robinson Avenue
Oxford Science Park
Oxford OX4 4GA
United Kingdom
+44 (0)845 034 7900
+44 (0)845 034 7901
http://www.nanoporetech.com
Gordon Sanghera
+44 (0)845 034 7900

Company Facts
Founded:
Founders:
CEO:Gordon Sanghera
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:
Category:Biotechnology & Healthcare
Sector:Biotechnology
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


26,807
Tech investments
From our Online Data Service
17,301
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 25€24.0MInternet commerce
Mar 23€2.0MInternet services
Mar 23€1.5MInternet services
Mar 23€110.0MInternet commerce
Mar 21€1.9MBusiness applications
Mar 20€1.0MInternet commerce
Mar 20€12.0ME-Commerce

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.